
Sign up to save your podcasts
Or


This episode was recorded May 22, 2020
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
SARS-CoV-2, as an RNA virus, has marked capacity for mutation and recombination events. How do we build an efficacious and safe vaccine against it? How could we safely speed up development? Is a vaccine neutralizing the spike protein enough? Dr. Greg Poland returns to give you an update from the front lines of research on vaccine development and ongoing clinical trials.
'I Have A Dream' Speech, In Its Entirety
https://www.npr.org/2010/01/18/122701268/i-have-a-dream-speech-in-its-entirety
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.4
268268 ratings
This episode was recorded May 22, 2020
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
SARS-CoV-2, as an RNA virus, has marked capacity for mutation and recombination events. How do we build an efficacious and safe vaccine against it? How could we safely speed up development? Is a vaccine neutralizing the spike protein enough? Dr. Greg Poland returns to give you an update from the front lines of research on vaccine development and ongoing clinical trials.
'I Have A Dream' Speech, In Its Entirety
https://www.npr.org/2010/01/18/122701268/i-have-a-dream-speech-in-its-entirety
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

137 Listeners

320 Listeners

700 Listeners

497 Listeners

250 Listeners

259 Listeners

3,343 Listeners

1,156 Listeners

195 Listeners

90 Listeners

513 Listeners

364 Listeners

12 Listeners

253 Listeners

18 Listeners

15 Listeners

9 Listeners

430 Listeners

371 Listeners

45 Listeners

14 Listeners